- Home
- WRN vs YDES Comparison
WRN vs YDES Comparison
Compare WRN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WRN | YDES |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | Canada | Taiwan |
| Employees | N/A | N/A |
| Industry | Metal Mining | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.2M | 543.0M |
| IPO Year | 2006 | 2024 |
Fundamental Metrics
Financial Performance| Metric | WRN | YDES |
|---|---|---|
| Price | $2.15 | $7.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 663.5K |
| Earning Date | 11-05-2026 | 08-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $1.70 |
| 52 Week High | $4.26 | $22.00 |
Technical Indicators
Market Signals| Indicator | WRN | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 71.98 |
| Support Level | $2.02 | $2.33 |
| Resistance Level | $2.34 | $9.11 |
| Average True Range (ATR) | 0.10 | 0.89 |
| MACD | -0.03 | 0.43 |
| Stochastic Oscillator | 2.82 | 87.02 |
Price Performance
Historical ComparisonAbout WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project). The Casino can deliver the critical minerals necessary for the energy transition while serving as an engine for long-term economic growth and prosperity in the North.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.